Blog
Why Adobe Systems (ADBE) Dipped More Than Broader Market Today
In the latest close session, Adobe Systems (ADBE) was down 3.1% at $345.63. This change lagged the S&P 500's daily loss of 0.69%. Meanwhile, the Dow lost 0.55%, and the Nasdaq, a tech-heavy index
ASML (ASML) Sees a More Significant Dip Than Broader Market: Some Facts to Know
ASML (ASML) closed the most recent trading day at $725.85, moving -2.26% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 0.69%. Meanwhile, the Dow
Boeing (BA) Rises As Market Takes a Dip: Key Facts
Boeing (BA) closed at $237.13 in the latest trading session, marking a +1.04% move from the prior day. The stock's change was more than the S&P 500's daily loss of 0.69%. Meanwhile, the Dow lost
Citigroup (C) Declines More Than Market: Some Information for Investors
Citigroup (C) ended the recent trading session at $94.71, demonstrating a -1.93% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 0.69%. At the same
Markets Sell Off on Noise About Tariffs, etc.
Tuesday, September 2, 2025It was a noisy day where market participants fought conflicting impulses today. Is U.S. tariff policy illegal? What will happen to the already collected revenues if it is
Top Analyst Reports for NVIDIA, Chevron & Booking
Tuesday, September 2, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA
Compared to Estimates, HealthEquity (HQY) Q2 Earnings: A Look at Key Metrics
HealthEquity (HQY) reported $325.84 million in revenue for the quarter ended July 2025, representing a year-over-year increase of 8.6%. EPS of $1.08 for the same period compares to $0.86 a year ago.
Zscaler (ZS) Q4 Earnings and Revenues Beat Estimates
Zscaler (ZS) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $0.88 per share a year ago. These figures are
HealthEquity (HQY) Q2 Earnings and Revenues Surpass Estimates
HealthEquity (HQY) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.86 per share a year ago. These
Verint Systems (VRNT) Q2 Earnings and Revenues Beat Estimates
Verint Systems (VRNT) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.49 per share a year ago. These
Are Investors Undervaluing Vontier (VNT) Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Should Value Investors Buy DaVita (DVA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Should Value Investors Buy Covenant Logistics Group (CVLG) Stock?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Are Investors Undervaluing Methanex (MEOH) Right Now?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Are Investors Undervaluing Continental (CTTAY) Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Should Value Investors Buy Columbia Banking System (COLB) Stock?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always
Should Value Investors Buy Lindblad Expeditions (LIND) Stock?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Should Value Investors Buy Post Holdings (POST) Stock?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Are Investors Undervaluing Integer Holdings (ITGR) Right Now?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Why Fast-paced Mover 3D Systems (DDD) Is a Great Choice for Value Investors
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that
Fast-paced Momentum Stock Penguin Solutions, Inc. (PENG) Is Still Trading at a Bargain
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that
Fast-paced Momentum Stock Visteon (VC) Is Still Trading at a Bargain
Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks
GMS (GMS) Shows Fast-paced Momentum But Is Still a Bargain Stock
Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and
Despite Fast-paced Momentum, Pediatrix Medical Group (MD) Is Still a Bargain Stock
Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and


